ESR1 and breast carcinoma: Many prognostic gene signatures have already been published in the global breast cancer population, and it was shown in a large comprehensive meta-analysis of publicly available expression data that these signatures are informative in the ER+/HER2- subtype and that proliferation-related genes are their common denominator [8].